NCT00480064View on ClinicalTrials.gov

Lomustine and Intermediate Dose Cytarabine in Older Patients With AML

PHASE3CompletedINTERVENTIONAL

Enrollment

360

Participants

Timeline

Start Date

July 31, 1995

Study Completion Date

May 31, 2007

Conditions

Acute Myeloid Leukemia

Interventions

DRUG

Lomustine, intermediate dose cytarabine

Trial Locations (1)

33604

Josy REIFFERS, MD MS, Pessac

All Listed Sponsors

lead

French Innovative Leukemia Organisation

OTHER